G
Grifols SA D
D
GRFS
8.09000
USD
-0.03
(-0.37%)
مغلق
حجم التداول
49,253
الربح لكل سهم
1
العائد الربحي
-
P/E
31
حجم السوق
5,504,509,651
الأخبار المقالات
العنوان: Grifols SA
القطاع: Healthcare
الصناعة: Drug Manufacturers - General
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.